Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Silence Therapeutics (DE:XRP2)
FRANKFURT:XRP2
Holding DE:XRP2?
Track your performance easily
Silence Therapeutics (XRP2) Ownership Overview
0.00%
Insiders
0.05% Mutual Funds
53.77% Other Institutional Investors
― ETFs
46.18% Public Companies and
Individual Investors
The ownership structure of Silence Therapeutics (DE:XRP2) stock is a mix of institutional, retail, and individual investors. , and 46.18% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $5149008 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $8367840 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 387,400 | Institution | 0.83% | 7,804,948 | |
| 238,380 | Institution | 0.51% | 4,802,642 | |
| 37,653 | Institution | 0.08% | 758,595 | |
| 22,427 | Institution | 0.05% | 451,837 | |
| 5,392 | Institution | 0.01% | 108,633 | |
| 4,591 | Institution | <0.01% | 92,495 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 22,427 | Institution | 0.05% | 451,837 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Silence Therapeutics (DE:XRP2)?
According to the latest TipRanks data, approximately 53.77% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 46.18% is held by retail investors.
What percentage of Silence Therapeutics (DE:XRP2) stock is held by institutional investors?
According to the latest TipRanks data, approximately 53.77% of Silence Therapeutics (DE:XRP2) stock is held by institutional investors.
What percentage of Silence Therapeutics (DE:XRP2) stock is held by retail investors?
According to the latest TipRanks data, approximately 46.18% of Silence Therapeutics (DE:XRP2) stock is held by retail investors.
Who owns the most shares of Silence Therapeutics (DE:XRP2)?
Stanley Druckenmiller owns the most shares of Silence Therapeutics (DE:XRP2).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.